Cortechs.ai software

For the assessment of multiple sclerosis and other neurodegenerative conditions. Automatically label, visualize and obtain the volumetric quantification of segmentable brain structures and lesions from MRI brain studies—within minutes. NeuroQuant MS combines T2 FLAIR with 3D T1 MR images to enhance your ability to identify and monitor the number and progression of brain lesions. Accurately visualizing lesions and lesion volume change enables you to deliver an efficient, objective assessment of disease activity, so you can determine the best course of treatment more quickly.

For the assessment of brain volumes for multiple sclerosis and age-associated neurodegenerative conditions. The NeuroQuant Multi-Structure Atrophy Report presents volumetric information for whole brain, superior lateral ventricles, thalamus, cortical gray matter, cerebral white matter, cerebral white matter hypointensities, 3d ventricle, hippocampus, and inferior lateral ventricles. The MSA report supports physicians in their assessment of patients aged 3-100.

For the assessment of traumatic brain injury and other neurodegenerative conditions. The NeuroQuant TBA Report provides physicians a quick reference and in-depth look on regional and global brain structure volumes, which could occur as a result of a brain injury or neurodegenerative disease, by providing volume measurements of 47 brain structures for both the right and left hemisphere, total structure – all sorted by lobe and region.

OnQ Neuro is FDA-cleared post-processing software used by radiologists, oncologists, and other clinicians to assist with the analysis and quantification of MR images of brain tumors.

OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS scoring.

Research advancements require advanced technology. PETQuant is a research-specific component of NeuroQuant® that provides researchers and physicians with a cutting-edge tool in the study of frontotemporal dementia and Alzheimer’s disease. PETQuant automatically quantifies PET tracer bindings localized to brain structures identified by NeuroQuant 3D T1 MRI segmentation. Users can select between two tracers for metabolic (FDG) and amyloid-based (Florbetapir) analysis. Visual and statistical (Z-score) comparisons of each normalized regional PET tracer value are then compared to normative population data. Compatible with GE, Philips, and Siemens PET and PET/CT scanners, PETQuant enables better insight that leads to breakthrough discoveries.

Cortechs.ai distribution and development partner. Subtle Medical is a healthcare technology company making medical imaging faster, safer, and smarter. Subtle Medical’s AI-powered software solutions, SubtlePET™ and SubtleMR™, provide the potential to radiology departments to increase workflow efficiency and improve the patient experience by enabling expedited MRI and PET image acquisition without compromising image quality. Subtle’s vendor-neutral solutions are a software upgrade to the entire fleet of MRI and PET machines that extends scanner life with the latest technology and reduces the need to purchase new equipment. The software is a quick and simple deployment with a significant long term impact.

Volumetric reporting for follow-up assessment of COVID-19 patients. Cortechs.ai is proud to be able to provide our volumetric reports as part of a COVID-19 neurological follow-up protocol using NeuroQuant, the most widely used clinical brain morphometry tool. LesionQuant FLAIR Lesion report, NeuroQuant Triage Brain Atrophy (TBA) and Custom COVID-19 reports are available as part of a suggested COVID-19 protocol available on our NeuroQuant 3.0.2 cloud-based system.